The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
Lara M. Lange(National Institute on Aging), Pedro Chaná(Central South University), Claire E. Shepherd(UNSW Sydney), Honglei Chen(Central South University), Zaruhi Tavadyan(National Institute of Health), Sarah Camargos(Universidade Federal de Minas Gerais), Kristin Levine(National Institutes of Health), Miguel E. Rentería(QIMR Berghofer Medical Research Institute), Zih‐Hua Fang(Benue State University), Alexander Zimprich(Ludwig-Maximilians-Universität München), M. Leonor Bustamante(University of Chile), Edward A. Fon(Montreal Neurological Institute and Hospital), Hampton L. Leonard(National Institutes of Health), Paula Saffie Awad(Universidade Federal do Rio Grande do Sul), Oury Monchi(University of Calgary), Marcelo Kauffman(Hospital Ramos Mejía), Christine Klein(University Hospital Schleswig-Holstein), Mike A. Nalls(University of Namur), Alberto J. Espay(University of Cincinnati), Sulev Kõks(Murdoch University), Patricio Olguı́n(University of Chile), Niccolò E. Mencacci(Universität Hamburg), Susan H. Fox(University of Toronto), Luca Marsili(University of Cincinnati), Stewart A. Factor(Georgetown University), Artur Francisco Schumacher Schuh(Universidade Federal do Rio Grande do Sul), Samson Khachatryan(National Institute of Health), Carlos Roberto de Mello Rieder(Universidade Federal do Rio Grande do Sul), Connie Marras(University of Toronto), Cornelis Blauwendraat(National Institutes of Health), Melina Ellis(The University of Sydney), Kishore R. Kumar(The University of Sydney), Peter Bauer(Bioinova (Czechia)), Huw R. Morris(University College London), Dan Vitale(National Institutes of Health), Christian Beetz(Jena University Hospital), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Emilia Gatto(Universidad de Buenos Aires), Benjamin Pizarro Galleguillos(Fundación Chile), Ted Fon(McGill University), Andrew Singleton(Laboratory of Molecular Genetics), Jessica Martin(National Institutes of Health), Nicole Kuznetsov(National Institutes of Health), Lenora A. Higginbotham(Emory University), Marcelo Miranda(Fundación Chile), Vítor Tumas(Universidade de São Paulo), Julie Hunter(Garvan Institute of Medical Research), Katja Lohmann(University of Lübeck)
Cited by 3
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Neurology|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k